Sifting through countless of stocks in the Software industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in Dolby Laboratories, Inc. or Cellebrite DI Ltd. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.

Read on to learn how Dolby Laboratories, Inc. and Cellebrite DI Ltd. compare based on key financial metrics to determine which better meets your investment needs.

About Dolby Laboratories, Inc. and Cellebrite DI Ltd.

Dolby Laboratories, Inc. engages in the design and manufacture of audio, imaging, accessibility, and other hardware and software solutions for television, broadcast, and live entertainment industries in the United States and internationally. The company develops and licenses its audio technologies, such as AAC, HE-AAC, and extended HE-AAC, a digital audio codec solution; AVC, a digital video codec used in STBs, mobile devices, cameras, and broadcast television services and other products; and Dolby Atmos and Dolby Vision include encoding technologies that artists use to create more compelling and immersive audio and video experiences. It also provides DD+, an advanced surround sound audio codec technology; Dolby AC-4, an audio codec that uses cutting edge compression; and HEVC, a digital video codec that compresses video. In addition, the company offers Dolby Cinemas, a premium large format cinemas that deliver a Dolby branded premium cinema offering with Dolby Vision, Dolby Atmos, and a Dolby theater design; Dolby.io, a SaaS product of immersive, interactive, and social experiences with real-time engagement for live events, especially sports; and digital cinema servers, cinema processors, amplifiers, loudspeakers, and audio and imaging hardware and software products for the cinema, television, broadcast, communication, and entertainment industries. Further, it provides various services to support theatrical and television production for cinema exhibition, broadcast, and home entertainment. It serves film studios, content creators, post-production facilities, and broadcasters. Dolby Laboratories, Inc. was founded in 1965 and is headquartered in San Francisco, California.

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company’s DI suite of solutions allows users to access, collect, review, extract, decode, decrypt, analyze, share, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company’s digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Endpoint Mobile Now; and professional services, such as training and certification services, and advanced services. It serves federal and state and local agencies. The company was founded in 1999 and is headquartered in Petah Tikva, Israel.

Latest Software and Dolby Laboratories, Inc., Cellebrite DI Ltd. Stock News

As of February 12, 2026, Dolby Laboratories, Inc. had a $6.4 billion market capitalization, compared to the Software median of $899.9 million. Dolby Laboratories, Inc.’s stock is NA in 2026, NA in the previous five trading days and down 20.29% in the past year.

Currently, Dolby Laboratories, Inc.’s price-earnings ratio is 26.9. Dolby Laboratories, Inc.’s trailing 12-month revenue is $1.3 billion with a 18.0% net profit margin. Year-over-year quarterly sales growth most recently was -2.9%. Analysts expect adjusted earnings to reach $4.355 per share for the current fiscal year. Dolby Laboratories, Inc. currently has a 2.2% dividend yield.

Currently, Cellebrite DI Ltd. does not have a price-earnings ratio. Cellebrite DI Ltd.’s trailing 12-month revenue is $436.7 million with a 16.5% net profit margin. Year-over-year quarterly sales growth most recently was 47.7%. Analysts expect adjusted earnings to reach $0.552 per share for the current fiscal year. Cellebrite DI Ltd. does not currently pay a dividend.

How We Compare Dolby Laboratories, Inc. and Cellebrite DI Ltd. Stock Grades

Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.

AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at Dolby Laboratories, Inc. and Cellebrite DI Ltd.’s stock grades to see how they measure up against one another.

Learn more about A+ Investor here!

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

Dolby Laboratories, Inc. and Cellebrite DI Ltd. Growth Grades

Company	Ticker	Growth
Dolby Laboratories, Inc.	DLB	C
Cellebrite DI Ltd.	CLBT	B

The foundation of growth investing is seeking out stocks of companies exhibiting strong, consistent and prolonged growth that is expected to continue into the future.

In order to compute the growth score and assign it a letter grade, the percentile ranks for each of three components‐consistency of annual sales growth, five-year sales growth rankings adjusted for extreme levels, and consistency of positive annual cash from operations‐must be determined. These three rank figures are added together, and the sum is ranked against the entire stock universe to arrive at a company’s Growth Score to create an equal distribution of grades.

The companies in the bottom 20% of the stock universe receive Growth Grades of F, considered to be very weak, while those in the top 20% receive A grades, which are considered very strong.

Dolby Laboratories, Inc. has a Growth Score of 59, which is Average. Cellebrite DI Ltd. has a Growth Score of 69, which is Strong.

The Growth Grade Winner: Cellebrite DI Ltd.

As you can clearly see from the Growth Grade breakdown above, Cellebrite DI Ltd. has a more attractive growth grade than Dolby Laboratories, Inc.. For investors who focus solely on how a company is growing relative to other companies in the same industry, Cellebrite DI Ltd. could be a good stock to add to their portfolio. However, it’s important for investors to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Dolby Laboratories, Inc. and Cellebrite DI Ltd.’s Momentum Grades

Company	Ticker	Momentum
Dolby Laboratories, Inc.	DLB	D
Cellebrite DI Ltd.	CLBT	F

Momentum grades help to uncover stocks experiencing anomalously high rates of return; research finds that stocks with high relative levels of momentum tend to outperform, whereas those with low levels of momentum tend to continue underperforming. Momentum is based on the price change of a stock over a specified period relative to all other stocks.

Typically, AAII looks at the weighted relative strength over the trailing four quarters. The weighted four-quarter relative strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40% and each of the three previous quarters are given a weighting of 20%.

Dolby Laboratories, Inc. has a Momentum Score of 29, which is Weak. Cellebrite DI Ltd. has a Momentum Score of 16, which is Very Weak.

The Momentum Stock Winner: No Clear Winner

Neither Dolby Laboratories, Inc. or Cellebrite DI Ltd. has a strong enough Momentum Grade to be considered a “winner.” Investors considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolios. It’s important to look at a wide range of financial metrics in order to determine if Dolby Laboratories, Inc. or Cellebrite DI Ltd. is the better investment when it comes to momentum.

Dolby Laboratories, Inc. and Cellebrite DI Ltd.’s Estimate Revisions Grades

Company	Ticker	Earnings Estimate
Dolby Laboratories, Inc.	DLB	B
Cellebrite DI Ltd.	CLBT	C

Earnings estimate revisions scores consider the magnitude of a company’s earnings surprise in its last two reported fiscal quarters. Often, positive surprises beget further positive surprises‐or at least continued sales growth (the exact opposite is generally true, too).

Estimate revisions offer an indication of what analysts are thinking about the short-term prospects of a firm. Estimate revisions are based on the statistical significance of a firm’s last two quarterly earnings surprises and the percentage change in its consensus estimate for the current fiscal year over the past month and past three months.

Dolby Laboratories, Inc. has a Earnings Estimate Score of 74, which is Positive. Cellebrite DI Ltd. has a Earnings Estimate Score of 54, which is Neutral.

The Earnings Estimate Revisions Grade Winner: Dolby Laboratories, Inc.

As you can clearly see from the Earnings Estimate Revisions Grade breakdown above, Dolby Laboratories, Inc. has a better Earnings Estimate Revisions Grade than Cellebrite DI Ltd.. For those who are specifically looking for companies with better short-term prospects when compared to other companies in the same industry, Dolby Laboratories, Inc. could be a good stock to invest in. However, it’s important to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Other Dolby Laboratories, Inc. and Cellebrite DI Ltd. Grades

In addition to Estimate Revisions, Growth and Momentum, A+ Investor also provides grades for Value and Quality.

Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection. Buying stocks that are going to go up typically means buying stocks that are undervalued in the first place, although momentum investors may argue that point.

AAII’s A+ Investor Quality Grade comes from the ranking of key metrics. Specifically, the quality grade is the percentile rank of the composite of return on assets (ROA), return on invested capital (ROIC), gross profit relative to assets, buyback yield, change in total liabilities to assets, accruals, Z double prime bankruptcy risk (Z) score and F-Score.

These 2 key factors, when combined with the above, provide a holistic view into a particular stock. Further, by joining A+ Investor you can see whether Dolby Laboratories, Inc. and Cellebrite DI Ltd. pass any of our 60+ stock screens that have outperformed the market since their creation.

So, Which Is the Better Investment, Dolby Laboratories, Inc. or Cellebrite DI Ltd. Stock?

Overall, Dolby Laboratories, Inc. stock has a Growth Score of 59, Momentum Score of 29 and Estimate Revisions Score of 74.

Cellebrite DI Ltd. stock has a Growth Score of 69, Momentum Score of 16 and Estimate Revisions Score of 54.

Comparing Dolby Laboratories, Inc. and Cellebrite DI Ltd.’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset allocation as well as your risk tolerance and financial goals to see if either of these stocks would make a good fit for you. AAII can help you figure out which investments align with your individual needs and preferences.

Investors are encouraged to do their own due diligence and research. In this way, individuals can effectively become managers of their own assets‐without having to rely on others for financial independence. You can count on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis.

A+ Investor adds to our qualitative teaching with a powerful data suite to help you whittle down investment choices to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.

AAII Disclaimer

We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith, and we accept no liability for any errors or omissions. The full disclaimer can be read here.